Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer

Mina Swiha, Sarennya Pathmanandavel, Nathan Papa, Zahra Sabahi, Sherrington Li, Alex Zheng, Sobia Khan, Maria Ayers, Shikha Sharma, Megan Crumbaker, Andrew Nguyen, Lyn Chan, Narjess Ayati and Louise Emmett
Journal of Nuclear Medicine October 2024, jnumed.124.267606; DOI: https://doi.org/10.2967/jnumed.124.267606
Mina Swiha
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
2Molecular Imaging and Theranostics Division, Department of Medical Imaging, University of Western Ontario, London, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarennya Pathmanandavel
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Papa
3Garvan Institute of Medical Research, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zahra Sabahi
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherrington Li
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Zheng
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sobia Khan
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Ayers
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shikha Sharma
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan Crumbaker
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
3Garvan Institute of Medical Research, Sydney, New South Wales, Australia; and
4St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Nguyen
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
4St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lyn Chan
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Narjess Ayati
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
3Garvan Institute of Medical Research, Sydney, New South Wales, Australia; and
4St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Emmett
1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
3Garvan Institute of Medical Research, Sydney, New South Wales, Australia; and
4St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.124.267606
DOI 
https://doi.org/10.2967/jnumed.124.267606
PubMed 
39477497

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 12, 2024
  • Accepted for publication September 30, 2024
  • Published online October 30, 2024.

Article Versions

  • You are currently viewing a previous version of this article (October 30, 2024 - 08:04).
  • View the most recent version of this article
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Mina Swiha1,2,
  2. Sarennya Pathmanandavel1,
  3. Nathan Papa3,
  4. Zahra Sabahi1,
  5. Sherrington Li1,
  6. Alex Zheng1,
  7. Sobia Khan1,
  8. Maria Ayers1,
  9. Shikha Sharma1,
  10. Megan Crumbaker1,3,4,
  11. Andrew Nguyen1,4,
  12. Lyn Chan1,
  13. Narjess Ayati1,3,4 and
  14. Louise Emmett1,3,4
  1. 1Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia;
  2. 2Molecular Imaging and Theranostics Division, Department of Medical Imaging, University of Western Ontario, London, Ontario, Canada;
  3. 3Garvan Institute of Medical Research, Sydney, New South Wales, Australia; and
  4. 4St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia
  1. For correspondence or reprints, contact Mina Swiha (mina.swiha{at}gmail.com).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
    Lena M. Unterrainer, Nicolas De Leiris, Marcus Unterrainer, Astrid Delker, Linus Hempel, Zachary Ells, Sophie C. Kunte, Josef Zahner, Adrien Holzgreve, Mathias J. Zacherl, Gabriel T. Sheikh, Jozefina Casuscelli, Julien Leenhardt, Kenneth J. Pienta, Emmanuelle Jacquet, Mathieu Laramas, Jerome Long, Marine Faure, Ghislaine Reboulet, Channing J. Paller, Alexis Mercier, Lilja B. Solnes, Kevin Kiraz, Harun Ilhan, Andrei Gafita, Loïc Djaileb
    Journal of Nuclear Medicine 2025

Article usage

Article usage: October 2024 to April 2025

AbstractFullPdf
Oct 20244413119
Nov 20243789224140
Dec 2024190712087
Jan 20257155437
Feb 20253913617
Mar 20252402016
Apr 20252603216
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer
Mina Swiha, Sarennya Pathmanandavel, Nathan Papa, Zahra Sabahi, Sherrington Li, Alex Zheng, Sobia Khan, Maria Ayers, Shikha Sharma, Megan Crumbaker, Andrew Nguyen, Lyn Chan, Narjess Ayati, Louise Emmett
Journal of Nuclear Medicine Oct 2024, jnumed.124.267606; DOI: 10.2967/jnumed.124.267606

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer
Mina Swiha, Sarennya Pathmanandavel, Nathan Papa, Zahra Sabahi, Sherrington Li, Alex Zheng, Sobia Khan, Maria Ayers, Shikha Sharma, Megan Crumbaker, Andrew Nguyen, Lyn Chan, Narjess Ayati, Louise Emmett
Journal of Nuclear Medicine Oct 2024, jnumed.124.267606; DOI: 10.2967/jnumed.124.267606
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • [177Lu]Lu-PSMA
  • [177Lu]Lu-PSMA SPECT
  • PSMA PET
  • prostate cancer
SNMMI

© 2025 SNMMI

Powered by HighWire